// THEME
mRNA Therapeutics Platforms
Biotechnology companies developing mRNA-based therapeutic modalities beyond vaccines, including cancer and rare disease treatments.
COMPANIES 4VELOCITY — STABLECAPITAL 28D $30.0M · 1 DEAL
TOP INVESTORS: general catalyst (2) · leaps by bayer (2) · amplify partners (1) · bain capital (1) · cpp investments (1)
CAPITAL FIGURES ARE MEDIA-EXTRACTED ESTIMATES, NOT VERIFIED FILINGS.
Capital raised, weekly
Deals by stage
series a
$380M · 4 DEALS
seed
$12M · 1 DEAL
series b
$180M · 1 DEAL
EXTRACTED FROM 25+ PODCASTS & VC NEWSLETTERS · MEDIA-REPORTED FIGURES, NOT VERIFIED FILINGS
// COMPANIES
4 COMPANIES
Celea Therapeutics
$30M · SERIES A EXTENSION · ELI LILLY + ORBIMED · AUG 19
3 SIGNALS · LAST SEEN AUG 19, 2026
Beeline Medicines
$126M · SERIES A · CPP INVESTMENTS + BAIN CAPITAL · JUL 14
2 SIGNALS · LAST SEEN JUL 14, 2026
Moderna
modernatx.com$98M · SERIES A · GENERAL CATALYST + KLEINER PERKINS · JUN 24
6 SIGNALS · LAST SEEN AUG 13, 2026
Tahoe Therapeutics
$12M · SEED · GENERAL CATALYST · MAY 31
1 SIGNAL · LAST SEEN JUN 1, 2026